yup, its crazy.
$3.6b approx value for success in all 4 indications, with a combined market dwarfing the current Rett community, then add royalties and commissions...and nevermind the other potential applications for the drug...
Granted there is a LONG way to go before every box is ticked...and under the banner of Neuren it mightnt eventuate...but to value it at around $3.6b is just so lame !!
"Better to remain silent and be thought a fool than to speak and to remove all doubt - It's better to keep your mouth shut and appear stupid."
Abraham Lincoln
Neuren Media and Analyst Coverage, page-748
-
- There are more pages in this discussion • 397 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.86 |
Change
0.640(3.17%) |
Mkt cap ! $2.666B | |||
| Open | High | Low | Value | Volume |
| $20.45 | $21.10 | $20.39 | $9.299M | 447.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 671 | $20.85 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.86 | 262 | 1 |
View Market Depth
| Last trade - 16.10pm 26/06/2024 (20 minute delay) ? |
| NEU (ASX) Chart |